Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Eylea
Pharma
Regeneron touts 'favorable' physician reports on Eylea HD
After Roche said it was starting to establish Vabysmo as the new standard of care in AMD and DME, Regeneron answered with the same claim about Eylea.
Kevin Dunleavy
Feb 2, 2024 11:09am
Viatris' Eylea biosimilar knocked down by patent court
Dec 29, 2023 10:01am
With high-dose Eylea launch, Regeneron eyes battle with Roche
Nov 2, 2023 11:44am
Roche's Vabysmo snares FDA nod to treat retinal vein occlusion
Oct 27, 2023 11:07am
Roche's Vabysmo shows durability in retinal vein occlusion
Oct 10, 2023 10:21am
Regeneron sprinkles fame on Debbie Allen-backed health campaign
Sep 20, 2023 7:45am